Abionic
Manufacturing · Switzerland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Route De La Corniche 5, Epalinges, Vaud,...Phone Number
+41 213533380Website
www.abionic.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Abionic
Abionic is a Swiss MedTech company founded in 2010, recognized for its innovation in rapid diagnostic solutions, winning multiple awards including Swiss MedTech of the year in 2023. Their flagship product, the abioSCOPE, is a near-patient diagnostic platform that provides lab-quality results from a single drop of blood within minutes, enabling timely clinical decisions at the point-of-care. The technology is designed to seamlessly integrate into emergency and intensive care workflows, allowing for efficient and accurate diagnosis of conditions like sepsis. Abionic aims to serve healthcare professionals and institutions globally by enhancing diagnostic capabilities and improving patient outcomes.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Abionic your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Abionic had a recent Job posting/layoffs
Abionic, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Abionic has new funding data
Check if Abionic has recently received funding, and reach out quickly before it becomes old news!
Check out if Abionic is spiking on competitors!
Earning: See what the market has to say on Abionic recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Abionic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Abionic launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Abionic as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Abionic is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Abionic is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Abionic.
Abionic financials insights
Gather financial insights about Abionic, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Series A
$3.7M
2014
Series B
$4M
Abionic Tech Stack
Abionic News & Media
Abionic Receives IVDR Certification for Its Predictive Ultra-Rapid Sepsis Test Allowing the Management of Antibiotic Administration
LAUSANNE, Switzerland--(BUSINESS WIRE)-- #AMR--Abionic SA, a developer of disruptive nanotechnology-based diagnostic solutions, has announced that its Pancreatic Stone Protein (PSP) test on the abioSCOPE® has been certified by BSI certification agency as complying with the European In-vitro Diagnostic Regulation (IVDR), EU 2017/746. This certification granted by notified bodies like BSI is required for in-vitro diagnostics to continue being sold in the European Union. The IVDR’s extensive requirAbionic launches ultra-fast on site COVID-19 Saliva Test aimed at schools, hotels, airports and restaurants
- Reliable and accurate test will provide unequivocal results in 1 minute, compared to rapid antigen tests (30 minutes) - Designed to be used at schools, events, companies, hotels, or airports, where swift diagnosis matter. - Reliable and easy-to-use, for the qualitative detection of...Abionic führt den ersten Covid-19-Schweregrad-Score ein, um die Patienten-Triage zu erleichtern
BIOPÔLE, LAUSANNE, Schweiz--(BUSINESS WIRE)--Abionic SA, ein Schweizer Medtech-Unternehmen mit Sitz in Lausanne, hat den cSOFA-Score entwickelt, ein neuartiges Maß zur Bewertung des Schweregrads von Covid-19. Der cSOFA-Score (Covid Sequential Organ Failure Assessment) misst die Wahrscheinlichkeit einer klinischen Verschlechterung bei Covid-19-Patienten und ermöglicht die Triage und Zuweisung auf die allgemeine Station oder Intensivstation (ICU) bei der Aufnahme und während des KrankenhausaufentAbionic Launches First Covid-19 Severity Test to Triage Patients Quickly and Accurately
BIOPÔLE LAUSANNE, Switzerland--(BUSINESS WIRE)--Abionic launches first Covid-19 severity test to triage patients quickly and accurately
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Abionic
Sign Up For FreeTo access detailed company insights
Abionic is a Swiss MedTech company founded in 2010, recognized for its innovation in rapid diagnostic solutions, winning multiple awards including Swiss MedTech of the year in 2023. Their flagship product, the abioSCOPE, is a near-patient diagnostic platform that provides lab-quality results from a single drop of blood within minutes, enabling time... Read More
